Medizone Intl. (fka MZEIQ)

[leporello]

$3.00 sp values the company at around 900 M...roughly what J+J paid for a dud technology. The question for shareholders of MZEI is how management develops the intrinsic value of the company.
We all know the many applications of the technology but we will only be rewarded if our leaders can demonstrate commercial viability(=orders).
In 2008 this company was on a death watch. Now we've got scientific proof of top level killing of bugs, a research facility in Ontario, dedicated medical personnel, a collaborative effort at NML in Canada, etc. We are off the mat but now we have to go another ten rounds. Should be a very interesting voyage...is there a pot of gold at the end of this rainbow? It's up to management now.